MENUNews Archive
Date: 09/15/2022
The second annual Colorful event is an evening of celebration and support of cancer research at the Rogel Cancer Center, the No. 1 ranked cancer program in Michigan. The evening will include both in-person and virtual options. Colorful will be a talk-show-style event hosted by NFL alums Dhani Jones with special guest Devon Still, and will include comments from Rogel researchers and patients.
Date: 09/12/2022
Drugs like enzalutamide that inhibit male hormones from activating the androgen receptor have been used to treat advanced prostate cancer for more than a decade. While successful in most cases, these drugs can eventually stop working, but there is a limited understanding about how this change occurs.
Date: 09/09/2022
For decades, researchers at the University of Michigan Rogel Cancer Center have been searching for ways to fundamentally change the approach to treating laryngeal cancer and underlying assumptions to improve clinical care for patients. Laryngeal cancer can severely alter patients’ ability to talk and breathe. Treatment is limited, relying on aggressive surgery and insufficient therapeutics, which leaves patients with few options.
Date: 08/22/2022
Within a pancreatic cancer tumor, different cell types interact to facilitate the tumor’s growth. Researchers see disrupting this metabolic crosstalk as a compelling target for treatment.
Date: 08/16/2022
The Rogel Cancer Center has submitted the 2022 grant renewal application for the National Cancer Institute’s Cancer Center Support Grant. Every five years, the cancer center must submit a renewal application for continued funding under the CCSG. Earlier this summer, the Rogel Cancer Center team completed and submitted the most recent CCSG renewal application.
Date: 08/08/2022
Coaching patients to voice their concerns about their medical care and advocate for themselves can offset physicians’ racial bias so it doesn’t lead to inferior experiences for Black patients, a University of Michigan-led study found.
Date: 07/27/2022
Patients with relapsed multiple myeloma are resistant to commonly used treatments. Researchers are one step closer to understanding the genetic reason why.
Date: 07/26/2022
The University of Michigan Rogel Cancer Center was rated the best cancer hospital in Michigan and among the best nationwide by U.S. News & World Report “Best Hospitals” rankings for 2022-2023. Rogel is the only Michigan cancer program to be ranked.
Date: 06/20/2022
Scientists have been working to make a mouse model of this tumor to better understand the disease biology to support preclinical testing of novel drugs, but no one before has been successful. A Merkel cell polyomavirus is believed to cause about 80% of these tumors, but researchers have been unable to definitively show this in vivo.
Date: 06/07/2022
A study published in Nature Communications, led by Imad Shureiqi, M.D., shows that, pre-cancerous pancreatic lesions in mice, similar to those found in humans, contain higher levels of the transcriptional receptor peroxisome proliferator activated receptor-delta (PPARδ).